AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glysuit M 1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Bio Schutz Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glysuit M 1 Tablet SR

Diabex Duo 1mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose levels. Administer Diabex Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse reaction is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms – sweating, dizziness, headache, tremors – and appropriate countermeasures. Maintain regular mealtimes and carry a fast-acting glucose source, like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. Diabex Duo is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment. This medication may not be suitable for all patients. Pregnant or lactating women require prior medical consultation. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glysuit M 1 Tablet SR

The information is unavailable.

Uses of Glysuit M 1 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glysuit M 1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glysuit M 1 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume this medication with food.

Common Side effects of Glysuit M 1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glysuit M 1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glysuit M 1 Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

How Glysuit M 1 Tablet SR works:

Glysuit M 1 Tablet SR combines glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glysuit M 1 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glysuit M 1 Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Glysuit M 1 Tablet SR is contraindicated during lactation. Evidence indicates potential infant toxicity associated with this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glysuit M 1 Tablet SR, potentially requiring dosage modification. Consult a physician before use. Glysuit M 1 Tablet SR is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Glysuit M 1 Tablet SR, potentially requiring dosage modification. Medical advice is recommended. For those with mild to moderate liver disease, Glysuit M 1 Tablet SR is typically initiated at a low dose; however, it's contraindicated in patients with severe liver dysfunction.

What if you forget to take Glysuit M 1 Tablet SR :

Should you forget a Glysuit M 1 Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glysuit M 1 Tablet SR

LabelValue
Potential for Dependence None.
Medication Category Diabetes medication

FAQs on Glysuit M 1 Tablet SR

Store this medication in its original, tightly sealed container or packaging, following the storage guidelines provided on the label. Discard any leftover medication. Prevent access by children, pets, and others.
Glysuit M 1 Tablet SR use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse effect is particularly risky for individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms arise, discontinue Glysuit M 1 Tablet SR and seek immediate medical attention.
Glysuit M 1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when used with a healthy diet and physical activity. Glimepiride stimulates insulin release from the pancreas, reducing blood glucose. Metformin decreases liver glucose production and enhances insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Glysuit M 1 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glysuit M 1 Tablet SR use can indeed lead to Vitamin B12 deficiency by hindering its intestinal absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. Preventive measures, proposed by some researchers, include annual supplemental Vitamin B12 intake.
Glysuit M 1 Tablet SR can indeed lead to hypoglycemia, characterized by symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, regular blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glysuit M 1 Tablet SR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and a heightened likelihood of lactic acidosis.
Glysuit M 1 Tablet SR
45
MRP 55
18% off